REYNOLDS CAMERON JOHN (President and CEO) purchased 3.1% of their position (78.13K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $50.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/6/2025ACC: 0001477932-25-005494
DirectorOfficer· President and CEO
+78.13K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
78.13K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+78.13K
Price / share
$0.64
Trade value
$50K
% of position
3.1%
—
2.53M→2.61M
Total
Net shares
+78.13K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +78.13K | $0.64 | $50K | 3.1% | 2.53M | 2.61M |
| Total | +78.13K | $50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.01M
Common Stock
IndirectShares owned34.08K
Total
1.04M indirect1.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Common Stock | 34.08K | Indirect |
| Total | 1.04M | 1.04M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported